Evidence map›Paper›PMID 28572632›Full record

ArticleScientific reports2017

Label-Free Fluorescence Spectroscopy for Detecting Key Biomolecules in Brain Tissue from a Mouse Model of Alzheimer's Disease.

Lingyan Shi, Luyao Lu, George Harvey, Thomas Harvey, Adrián Rodríguez-Contreras, Robert R Alfano

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Unlocking autofluorescence in the era of full spectrum analysis: Implications for immunophenotype discovery projects.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Lingyan ShiInstitute for Ultrafast Spectroscopy and Lasers, the City College of the City University of New York, New York, NY, USA.
Luyao LuDepartment of Biomedical Engineering, Wenzhou Medical University, Zhejiang, China.
George HarveyRiverdale Country School, Bronx, NY, USA.
Thomas HarveyRiverdale Country School, Bronx, NY, USA.
Adrián Rodríguez-ContrerasInstitute for Ultrafast Spectroscopy and Lasers, the City College of the City University of New York, New York, NY, USA.
Robert R AlfanoInstitute for Ultrafast Spectroscopy and Lasers, the City College of the City University of New York, New York, NY, USA. ralfano@ccny.cuny.edu.
City College of New York · USCity University of New York · USWenzhou Medical University · CN

Funding

TNC FUNCTION IN APOPTOTIC ANTIGEN DRIVEN AUTOIMMUNITYG12RR003060 · NCRR · CITY COLLEGE OF NEW YORK · PI GUYDEN, JERRY · 1985 to 2011
$26.1M
Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
Neuronal ensembles during development of tonotopic maps in the auditory systemsSC1HD068129 · NICHD · CITY COLLEGE OF NEW YORK · PI RODRIGUEZ-CONTRERAS, ADRIAN · 2010 to 2014
$1.1M
NCRR NIH HHS G12 RR003060NICHD NIH HHS SC1 HD068129NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

In this study, label-free fluorescence spectroscopy was used for the first time to determine spectral profiles of tryptophan, reduced nicotinamide adenine dinucleotide (NADH), and flavin denine dinucleotide (FAD) in fresh brain samples of a mouse model of Alzheimer's disease (AD). Our results showed that the emission spectral profile levels of tryptophan and NADH were higher in AD samples than normal samples. The intensity ratio of tryptophan to NADH and the change rate of fluorescence intensity with respect to wavelength also increased in AD brain. These results yield an optical method for detecting early stage of AD by comparing spectral profiles of biomolecules.

Indexed as

Alzheimer DiseaseAnimalsBrainDisease Models, AnimalEarly DiagnosisFlavin-Adenine DinucleotideHumansMiceMice, TransgenicNADSpectrometry, FluorescenceTryptophanFlavin-Adenine DinucleotideNADTryptophan

Identifiers

PMID28572632
PMCPMC5454017
OpenAlexW2620492190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.